Similar articles

• Amino-terminal pro-B-type natriuretic peptide: analytic considerations.

  Ordonez-Llanos J, Collinson PO, Christenson RH. Ordonez-Llanos J, et al. Am J Cardiol. 2008 Feb 4;101(3A):9-15. doi: 10.1016/j.amjcard.2007.11.013. Am J Cardiol. 2008. PMID: 18243867 Review.
• Amino-terminal pro-B-type natriuretic peptides: testing in general populations.

  de Lemos JA, Hildebrandt P. de Lemos JA, et al. Am J Cardiol. 2008 Feb 4;101(3A):16-20. doi: 10.1016/j.amjcard.2007.11.014. Am J Cardiol. 2008. PMID: 18243852 Review.
• B-type natriuretic peptides for the evaluation of exercise intolerance.

  Mueller C, Maeder MT, Christ A, Reichlin T, Staub D, Noveanu M, Breidthardt T, Potocki M, Brutsche MH. Mueller C, et al. Am J Med. 2009 Mar;122(3):265-72. doi: 10.1016/j.amjmed.2008.08.030. Am J Med. 2009. PMID: 19272488
• Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?

  Campbell DJ. Campbell DJ. Clin Exp Pharmacol Physiol. 2008 Apr;35(4):442-6. doi: 10.1111/j.1440-1681.2008.04894.x. Clin Exp Pharmacol Physiol. 2008. PMID: 18307738 Review.
• [NT-proBNP in practice: from chemistry to medicine].

  Jourdain P, Lefèvre G, Oddoze C, Sapin V, Dievart F, Jondeau G, Meune C, Galinier M. Jourdain P, et al. Ann Cardiol Angeiol (Paris). 2009 Jun;58(3):165-79. doi: 10.1016/j.ancard.2009.03.003. Epub 2009 Apr 25. Ann Cardiol Angeiol (Paris). 2009. PMID: 19457468 Review. French.